Friday, January 17, 2003
Transmeta posted stabilized losses and a slight revenue shrink for its Q4, which ended Dec. 27, 2002.
The company, which specializes in low-power microprocessors, posted a net revenue of $6.1 million, which is slightly below the previous quarter’s $6.4 million, but a marked improvement from Q4 2001’s $1.5 million revenue.
Transmeta posted a net loss of $21.7 million a marginal improvement on the previous quarter’s net loss of $21.8 million.
Transmeta said Q1 2003 would be very similar to Q4 2002. Revenues are expected to be the same, with a pro forma loss of 12 cents to 13 cents per share. For Q4, the company posted a pro forma net loss of $17.6 million, or 13 cents per share. Q1 operating expenses are expected to be flat at $20 million, with gross margins at 25 percent. This would leave Transmeta with cash reserves of $110 million.
Transmeta’s President and CEO Matthew Perry said the company remains on track to meet its goal of profitability by Q4 this year. He expects growth in the company during the second half of the year, as it begins volume shipments in mid-Q3 of its Crusoe TM8000 processor.
The chip features a completely different microarchitecture and improvements to the code-morphing hardware that the company uses to run x86 processors without a license from Intel who dominates the microprocessor space.
Financial results for Q4 2001 were severely hit by a delay in the TM5800’s rollout
By: DocMemory
Copyright © 2023 CST, Inc. All Rights Reserved
|
